Morphoceuticals is a TechBio company focused on understanding and manipulating the bioelectrome to induce regeneration and treat disease. The bioelectrome is the set of electrical communication networks within the body that bind multi-cellular collectives together for a common purpose, maintaining tissue and organ level integrity and health. We are building an atlas of the bioelectrome using our world-first suite of model systems and proprietary AI techniques. By understanding and manipulating these networks, we aim to rewrite them for the treatment of conditions that are inadequately addressed by existing therapeutic strategies. At Morphoceuticals, we are reprogramming the software of life. For more information visit www.morphoceuticals.com.
| Website | http://www.morphoceuticals.com |
| Employees | 7 (4 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Bioelectronics, Drug Discovery, Biotech Research, Tissue Repair, Organ Regeneration, Therapeutic Targets, Regenerative Medicine, Ai In Healthcare, Precision Medicine, Molecular Medicine, Pharmaceutical Research, Multiomics, Cellular Therapy, Electrical Networks, Biomarker Discovery, Health Technology, Medical Technology |
| Competitors | Dermalogica, Lumenis, Murad, Obagi, SkinCeuticals, ZO Skin Health, Inc., Dr. Dennis Gross Skincare, PCA SKIN, Jan Marini Skin Research, SkinMedica Inc., An Allergan Company +43 more (view full list) |
Looking for a particular Morphoceuticals, Inc. employee's phone or email?
Jim Jenson is the CEO, Director of Morphoceuticals, Inc..
4 people are employed at Morphoceuticals, Inc..
Morphoceuticals, Inc. is based in Medford, Massachusetts.